Does combined imaging of the pre- and postsynaptic dopaminergic system increase the diagnostic accuracy in the differential diagnosis of parkinsonism?

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 34, Issue 8, 2007, Pages 1265-1273

  Koch, Walter ^a   Hamann, Christine ^a   Radau, Perry E ^b   Tatsch, Klaus ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b SUNNYBROOK RESEARCH INSTITUTE   (Canada)

Author keywords

123I IBZM; Asymmetry; Automatic data processing; Quantitative evaluation

Indexed keywords

2 CARBOMETHOXY 3 (4 IODOPHENYL) N (3 FLUOROPROPYL)NORTROPANE IODINE 123; DOPAMINE 2 RECEPTOR; DOPAMINE TRANSPORTER; METHOXYBENZAMIDE IODINE 123; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; CALCULATION; CORPUS STRIATUM; DIAGNOSIS RELATED GROUP; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DOPAMINERGIC SYSTEM; EVALUATION; FEMALE; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; NON IDIOPATHIC PARKINSONIAN SYNDROME; PARKINSON DISEASE; PARKINSONISM; PRESYNAPTIC NERVE; PROBABILITY; QUANTITATIVE ANALYSIS; RECEIVER OPERATING CHARACTERISTIC; RECEPTOR BINDING; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

ADULT; AGED; AREA UNDER CURVE; AUTOMATION; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MALE; MIDDLE AGED; PARKINSONIAN DISORDERS; RECEPTORS, DOPAMINE D2; REPRODUCIBILITY OF RESULTS; ROC CURVE; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 34248999903     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-007-0375-8     Document Type: Article

References (44)

1. Rajput AH, Rozdilsky B, Rajput A. Accuracy of clinical diagnosis in parkinsonism-a prospective study. Can J Neurol Sci 1991;18:275-8.
2. Jankovic J, Rajput AH, McDermott MP, Perl DP. The evolution of diagnosis in early Parkinson disease. Parkinson Study Group. Arch Neurol 2000;57:369-72.
3. 3H]spiperone binding, dopamine and HVA concentrations in Parkinson's disease and supranuclear palsy. Eur J Pharmacol 1984;99:167-75.
4. Quinn N. Multiple system atrophy-the nature of the beast. J Neurol Neurosurg Psychiatry 1989;Suppl:78-89
5. Schwarz J, Kraft E, Vogl T, Arnold G, Tatsch K, Oertel WH. Relative quantification of signal on T2-weighted images in the basal ganglia: limited value in differential diagnosis of patients with parkinsonism. Neuroradiology 1999;41:124-8.
6. Booij J, Tissingh G, Winogrodzka A, van Royen EA. Imaging of the dopaminergic neurotransmission system using single-photon emission tomography and positron emission tomography in patients with parkinsonism. Eur J Nucl Med 1999;26:171-82.
7. Brucke T, Djamshidian S, Bencsits G, Pirker W, Asenbaum S, Podreka I. SPECT and PET imaging of the dopaminergic system in Parkinson's disease. J Neurol 2000;247 Suppl 4:IV/2-7.
8. Tatsch K. Imaging of the dopaminergic system in parkinsonism with SPET. Nucl Med Commun 2001;22:819-27.
9. 2 receptor ligands. Eur J Nucl Med Mol Imaging 2002;29:BP23-9.
10. 123I-IBZM SPECT for the diagnosis of parkinsonian syndromes: study on 72 patients. J Neural Transm 2005;112:677-92.
11. 2 receptor SPECT in the diagnostic evaluation of PD, MSA, and PSP. Mov Disord 2002;17:303-12.
12. Bettin S, Kampfer I, Seese A, Schafer A, Reuter M, Lossner J, et al. Striatal uptake of I-123-beta-CIT and I-123-IBZM in patients with extrapyramidal symptoms. Nuklearmedizin 1997;36:167-72.
13. 2 receptors in patients with Parkinson's disease and multiple system atrophy. Eur J Nucl Med Mol Imaging 2004;31:1631-8.
14. Koch W, Radau PE, Hamann C, Tatsch K. Clinical testing of an optimized software solution for an automated, observer-independent evaluation of dopamine transporter SPECT studies. J Nucl Med 2005;46:1109-18.
15. Popperl G, Radau P, Linke R, Hahn K, Tatsch K. Diagnostic performance of a 3-D automated quantification method of dopamine D2 receptor SPECT studies in the differential diagnosis of parkinsonism. Nucl Med Commun 2005;26:39-43.
16. Buchert R, Berding G, Wilke F, Martin B, von Borczyskowski D, Mester J, et al. IBZM tool: a fully automated expert system for the evaluation of IBZM SPECT studies. Eur J Nucl Med Mol Imaging 2006;33:1073-83.
17. 2 transporter ligands. Eur J Nucl Med Mol Imaging 2002;29:BP30-5.
18. 123I-IBZM uptake in the striatum applied to parkinsonism. J Nucl Med 2000;41:220-7.
19. Larisch R, Klimke A. Clinical impact of cerebral dopamine-D2 receptor scintigraphy. Nuklearmedizin 1998;37:245-50.
20. 123I-iodobenzamide-SPECT in 83 patients with de novo parkinsonism. Neurology 1993;43:S17-20.
21. 123I IBZM-SPECT. Mov Disord 1993;8:453-8.
22. Schneider JA, Watts RL, Gearing M, Brewer RP, Mirra SS. Corticobasal degeneration: neuropathologic and clinical heterogeneity. Neurology 1997;48:959-69.
23. Tissingh G, Booij J, Bergmans P, Winogrodzka A, Janssen AG, van Royen EA, et al. Iodine-123-N-omega-fluoropropyl-2beta-carbomethoxy-3beta-(4-iodophenyl) tropane SPECT in healthy controls and early-stage, drug-naive Parkinson's disease. J Nucl Med 1998;39:1143-8.
24. Rinne UK, Laihinen A, Rinne JO, Nagren K, Bergman J, Ruotsalainen U. Positron emission tomography demonstrates dopamine D2 receptor supersensitivity in the striatum of patients with early Parkinson's disease. Mov Disord 1990;5:55-9.
25. 11C]raclopride. Mov Disord 1997;12:33-8.
26. Ichise M, Kim YJ, Ballinger JR, Vines D, Erami SS, Tanaka F, et al. SPECT imaging of pre- and postsynaptic dopaminergic alterations in L-dopa-untreated PD. Neurology 1999;52:1206-14.
27. Gonzalez AM, Berciano J, Figols J, Pazos A, Pascual J. Loss of dopamine uptake sites and dopamine D2 receptors in striatonigral degeneration. Brain Res 2000;852:228-32.
28. Pascual J, Berciano J, Grijalba B, del Olmo E, Gonzalez AM, Figols J, et al. Dopamine D1 and D2 receptors in progressive supranuclear palsy: an autoradiographic study. Ann Neurol 1992;32:703-7.
29. 123I]beta-CIT SPECT imaging demonstrates reduced density of striatal dopamine transporters in Parkinson's disease and multiple system atrophy. Mov Disord 2001;16:1023-32.
30. 123I]beta-CIT and SPECT. Correlation with clinical findings and comparison with multiple system atrophy and progressive supranuclear palsy. J Neural Transm Suppl 1997;50:9-24.
31. 123I]beta-CIT striatal uptake correlates with symptom severity in Parkinson's disease. Ann Neurol 1995;38:589-98.
32. 123I]beta-CIT SPECT. J Neurol 1998;245:14-20.
33. 18F]beta-CFT in assessing disability in Parkinson's disease. J Neurol Neurosurg Psychiatry 1999;67:737-41.
34. Kim SE, Lee WY, Choe YS, Kim JH. SPECT measurement of iodine-123-beta-CIT binding to dopamine and serotonin transporters in Parkinson's disease: correlation with symptom severity. Neurol Res 1999;21:255-61.
35. Pirker W. Correlation of dopamine transporter imaging with parkinsonian motor handicap: how close is it? Mov Disord 2003;18 Suppl 7:S43-51.
36. Asenbaum S, Brucke T, Pirker W, Podreka I, Angelberger P, Wenger S, et al. Imaging of dopamine transporters with iodine-123-beta-CIT and SPECT in Parkinson's disease. J Nucl Med 1997;38:1-6.
37. 123I]beta-CIT SPECT in multiple system atrophy, progressive supranuclear palsy, and corticobasal degeneration. Mov Disord 2000;15:1158-67.
38. McNeill TH, Brown SA, Rafols JA, Shoulson I. Atrophy of medium spiny I striatal dendrites in advanced Parkinson's disease. Brain Res 1988;455:148-52.
39. Brooks DJ. PET studies on the early and differential diagnosis of Parkinson's disease. Neurology 1993;43:S6-16.
40. Rice JE, Thompson PD. 5: Movement disorders I: parkinsonism and the akinetic-rigid syndromes. Med J Aust 2001;174:357-63.
41. 11C]raclopride. J Cereb Blood Flow Metab 1993;13:310-4.
42. Wong DF, Young D, Wilson PD, Meltzer CC, Gjedde A. Quantification of neuroreceptors in the living human brain: III. D2-like dopamine receptors: theory, validation, and changes during normal aging. J Cereb Blood Flow Metab 1997;17:316-30.
43. 18F-N-methylspiroperidol. Psychiatry Res 1996;67:11-6.
44. Ichise M, Ballinger JR, Tanaka F, Moscovitch M, St George-Hyslop PH, Raphael D, et al. Age-related changes in D2 receptor binding with iodine-123-iodobenzofuran SPECT. J Nucl Med 1998;39:1511-8.